Novel association between graft rejection and post-transplant malignancy in solid organ transplantation

Figure 2 Landmark analysis of post-transplant malignancy risk in rejection-induced graft failure. A: No landmark; B: 1-year landmark; C: 2-year landmark; D: 3-year landmark; E: 5-year landmark; F: 10-year landmark; G: 15-year landmark; H: 20-year landmark. Recipients with rejection-induced graft failure had a lower risk of developing malignancy over time compared to those without rejection. RGF: Rejection-induced graft failure.